Sernova (TSE:SVA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova Corp., a biotech company advancing cell therapies for chronic diseases, has announced the appointment of biotech veteran David Paterson Ph.D. to its Board of Directors. Paterson’s extensive experience in corporate development and his biopharma industry knowledge are expected to bolster Sernova’s growth and its innovative Cell Pouch System technology, particularly in the type 1 diabetes sector.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
